REPLY TO: Serum Uric Acid Still Carries Controversies About Its Role in Endothelial Dysfunction

dc.contributor.authorKanbay, Mehmet
dc.contributor.authorTurak, Osman
dc.contributor.authorJohnson, Richard J.
dc.date.accessioned2025-05-10T19:40:12Z
dc.date.issued2013
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.1111/jch.12078
dc.identifier.endpage297
dc.identifier.issn1524-6175
dc.identifier.issn1751-7176
dc.identifier.issue4
dc.identifier.pmid23551732
dc.identifier.scopusqualityQ1
dc.identifier.startpage297
dc.identifier.urihttps://doi.org/10.1111/jch.12078
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9904
dc.identifier.volume15
dc.identifier.wosWOS:000317135700014
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Clinical Hypertension
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectHyperuricemia
dc.subjectHypertension
dc.subjectAllopurinol
dc.titleREPLY TO: Serum Uric Acid Still Carries Controversies About Its Role in Endothelial Dysfunction
dc.typeLetter

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9904.pdf
Boyut:
30.01 KB
Biçim:
Adobe Portable Document Format